Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_4
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution1 total trials
Phase 4Post-market surveillance
1(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (100.0%)

Trials by Status

completed250%
unknown125%
active_not_recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
active_not_recruiting

Intra-operative Pancreatoscopy in Patients With IPMN

NCT03729453
completed

Spy II Clinical Registry

NCT00751998
completed

SpyGlass Direct Visualization System Clinical Registry in China

NCT02287194
unknownphase_4

Endoscopic Treatment of Difficult Bile Duct Stones: Spyglass + EHL x Balloon Dilation of the Papilla

NCT02703077

Clinical Trials (4)

Showing 4 of 4 trials
NCT03729453

Intra-operative Pancreatoscopy in Patients With IPMN

Active Not Recruiting
NCT00751998

Spy II Clinical Registry

Completed
NCT02287194

SpyGlass Direct Visualization System Clinical Registry in China

Completed
NCT02703077Phase 4

Endoscopic Treatment of Difficult Bile Duct Stones: Spyglass + EHL x Balloon Dilation of the Papilla

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4